Title : Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation.

Pub. Date : 2017 Dec 21

PMID : 29269881






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation. Fatty Acids albumin Homo sapiens
2 Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was developed as a technique to extend the serum half-life in vivo by taking advantages of unusually long serum half-life of human serum albumin (HSA). Fatty Acids albumin Homo sapiens
3 Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was developed as a technique to extend the serum half-life in vivo by taking advantages of unusually long serum half-life of human serum albumin (HSA). Fatty Acids albumin Homo sapiens